- Home
- RUMBW vs SNN Comparison
RUMBW vs SNN Comparison
Compare RUMBW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUMBW
- SNN
- Stock Information
- Founded
- RUMBW 2013
- SNN 1856
- Country
- RUMBW United States
- SNN United Kingdom
- Employees
- RUMBW 135
- SNN N/A
- Industry
- RUMBW Computer Software: Prepackaged Software
- SNN Industrial Specialties
- Sector
- RUMBW Technology
- SNN Health Care
- Exchange
- RUMBW Nasdaq
- SNN Nasdaq
- Market Cap
- RUMBW N/A
- SNN 12.6B
- IPO Year
- RUMBW N/A
- SNN 1999
- Fundamental
- Price
- RUMBW $3.05
- SNN $29.96
- Analyst Decision
- RUMBW
- SNN Hold
- Analyst Count
- RUMBW 0
- SNN 3
- Target Price
- RUMBW N/A
- SNN $27.50
- AVG Volume (30 Days)
- RUMBW 39.1K
- SNN 900.6K
- Earning Date
- RUMBW 03-28-2025
- SNN 07-31-2025
- Dividend Yield
- RUMBW N/A
- SNN 2.40%
- EPS Growth
- RUMBW N/A
- SNN 56.15
- EPS
- RUMBW N/A
- SNN 0.47
- Revenue
- RUMBW $85,651,775.00
- SNN $5,810,000,000.00
- Revenue This Year
- RUMBW N/A
- SNN $6.87
- Revenue Next Year
- RUMBW N/A
- SNN $5.19
- P/E Ratio
- RUMBW N/A
- SNN $32.14
- Revenue Growth
- RUMBW 6.36
- SNN 4.70
- 52 Week Low
- RUMBW $4.32
- SNN $23.69
- 52 Week High
- RUMBW $4.68
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- RUMBW N/A
- SNN 54.99
- Support Level
- RUMBW N/A
- SNN $29.99
- Resistance Level
- RUMBW N/A
- SNN $30.77
- Average True Range (ATR)
- RUMBW 0.00
- SNN 0.39
- MACD
- RUMBW 0.00
- SNN 0.01
- Stochastic Oscillator
- RUMBW 0.00
- SNN 65.82
About RUMBW Rumble Inc. Warrant
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.